Pharmaceutical compositions for preventing or treating pulmonary metastasis of cancer including CHI3L1 inhibitor as active ingredient

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11524047
APP PUB NO 20210046151A1
SERIAL NO

16957249

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pharmaceutical compositions for preventing or treating pulmonary metastasis of cancer. More specifically, the present invention relates to compositions that enhance anti-cancer immunity of the lung rather than induce death of advanced cancer, thus being effective in inhibiting, preventing or treating pulmonary metastasis of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITYC/O HANYANG UNIVERSITY 222 WANGSIMNI-RO SEONGDONG-GU SEOUL 04763

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Choi, Je-Min Seoul, KR 11 13
Kim, Do-Hyun Seoul, KR 108 5365

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 13, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 13, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 13, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00